go-v.orgdoi

Exosomes derived from 5-fluorouracil-resistant colon cancer cells are enriched in GDF15 and can promote angiogenesis

Xixi Zheng, Nina Ma, Xingyu Wang, Jiexuan Hu, Xiao Ma, Jingting Wang, Bangwei Cao · Journal of Cancer · 2020

  • DOI 10.7150/jca.49224
  • Publisher Ivyspring International Publisher
  • Type article
  • Issued 2020

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Journal of Cancer · Ivyspring International Publisher · article · 2020

Abstract

Background: Angiogenesis is important for tumor proliferation and distant metastasis.However, the role of drug-resistant tumor cells in angiogenesis remains largely unknown.Current anti-angiogenic strategies also have limitations and it would be useful to develop novel targets and treatment strategies.Methods: Differential ultracentrifugation was used to isolate conditioned medium-derived exosomes from 5-flurouracil (5-FU)-sensitive or -resistant colon cancer cells.Exosome endocytosis into human umbilical vein endothelial cells was observed via immunofluorescence.Differentially expressed proteins in the exosomes were confirmed via qRT-PCR and Western blotting.The angiogenic capacity of endothelial cells was evaluated using cell function assays and a rat model of abdominal aortic neovascularization.The underlying mechanisms were verified using qRT-PCR and Western blotting assays.Immunohistochemistry was used to evaluate in vivo angiogenesis.

Results:We observed that the conditioned medium and exosomes from 5-FU-resistant colon cancer cells could promote angiogenesis.Exosomal growth/differentiation factor 15 (GDF15) was a potent inducer of this angiogenesis in vitro by inhibiting the Smad signaling pathway, thus increasing periostin (POSTN) levels.Moreover, 5-FU-resistant colon cancer cells showed high microvascular density in vivo.TGF-β1, an activator of the Smad signaling pathway, could partly eliminate those effects.Conclusions: Our study reveals the molecular regulation of angiogenesis in 5-FU-resistant colon cancer and suggests that the GDF15-POSTN axis may be a novel target for anti-angiogenic therapies in colon cancer.

Open the resolved locator · 10.7150/jca.49224

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 21:37 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://www.jcancer.org/v11p7116.htm
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.